GTC
NVAX icon

Ghost Tree Capital’s Novavax NVAX Stock Holding History

Ghost Tree Capital’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-17,500
Closed -$3.17M – 64
2021
Q1 		$3.17M Buy
+17,500
New +$3.49M 0.75% 39
2014
Q2 		– Sell
-5,000
Closed -$453K – 69
2014
Q1 		$453K Buy
+5,000
New +$559K 0.27% 58

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ghost Tree Capital's NVAX Position: Q2 2021 in Review

Ghost Tree Capital sold out of Novavax (NVAX) in Q2 2021, closing a stake of 17,500 shares — an estimated $3.17M sold.

Ghost Tree Capital first reported a position in NVAX in Q1 2014 and held it in 2 quarters. The position peaked at $3.17M in Q1 2021. 407 funds tracked by Wall St. Rank hold NVAX as of Q2 2021.

  • Ghost Tree Capital reported no remaining Novavax position as of Q2 2021 after selling out during the quarter.
  • Ghost Tree Capital sold 17,500 Novavax shares in Q2 2021, an estimated $3.17M.
  • Ghost Tree Capital first reported a position in Novavax in Q1 2014 and held it in 2 quarters.
  • Ghost Tree Capital's Novavax position peaked at $3.17M in Q1 2021.
  • 407 funds tracked by Wall St. Rank held Novavax as of Q2 2021.

Based on Ghost Tree Capital's 13F filing for Q2 2021, filed 11 Aug 2021.